Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil effects on pulmonary microvascular disease in symptomatic smokers
RBR-9t6rd7Not yet recruiting
- Sponsor
- Universidade Federal de Mato Grosso do Sul
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of sildenafil in Pulmonary Microvascular Disease (2 arms), sponsored by Universidade Federal de Mato Grosso do Sul. Primary endpoint: Exercise tolerance during constant-load cardiopulmonary exercise test. Planned start Feb 2020; status: not yet recruiting.
02
Drugs
sildenafil
03
Conditions
Pulmonary Microvascular Disease
Beyond the preview
Go deeper on RBR-9t6rd7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9t6rd7.